Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Regular Articles

Effective Adoptive Immunotherapy by T-LAK Cells Retargeted with Bacterial Superantigen-conjugated Antibody to MUC1 in Xenografted Severe Combined Immunodeficient Mice

Masao Shinoda, Toshio Kudo, Masanori Suzuki, Yu Katayose, Naoki Sakurai, Hisaaki Saeki, Hideaki Kodama, Kenji Fukuhara, Kohzoh Imai, Yuji Hinoda and Seiki Matsuno
Masao Shinoda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshio Kudo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masanori Suzuki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu Katayose
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoki Sakurai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisaaki Saeki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Kodama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Fukuhara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kohzoh Imai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Hinoda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seiki Matsuno
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published July 1998
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

To reinforce cytotoxic activity and the targeting ability of lymphokineactivated killer cells with a T-cell phenotype (T-LAK) for adoptive immunotherapy against human bile duct carcinoma (BDC), staphylococcal enterotoxin A (SEA) was conjugated chemically with MUSE11 monoclonal antibody (MUSE11 mAb), directed to the MUC1 antigen, using N-succinimidyl 3-(2-pyridyldithio) propionate and 2-iminothiolane HCl. Both SEA-conjugated MUSE11 mAb (SEA-MUSE11) and the F(ab')2 of MUSE11 mAb (SEA-F(ab')2) showed significant enhancement of T-LAK cell tumor neutralization for MUC1 positive-target tumor cells, even with a concentration of 0.01 µg/ml at an E:T ratio of 5:1 in vitro. In this in vitro test, MUC1-positive BDC cells were observed to attach to surrounding T-LAK cells in the presence of SEA-MUSE11 or SEA-F(ab')2. Remarkable tumor growth inhibition was observed in BDC-grafted severe combined immunodeficient mice to which 2 × 107 T-LAK cells preincubated with 2 µg of SEA-MUSE11 or SEA-F(ab')2, together with recombinant interleukin 2 (500 IU), were administered i.v. for 4 consecutive days, when tumor size was 5 mm in diameter. These results point to a promising adoptive immunotherapy for patients with BDC.

Footnotes

  • ↵1 This work was supported in part by Grant-in-Aid for Cancer Research 06279101 from the Ministry of Education, Science, Sports and Culture of Japan.

  • ↵2 To whom requests for reprints should be addressed, at the Cell Resource Center for Biomedical Research, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryomachi, Aoba-ku, Sendai 980-8575, Japan. Fax: 81-22-717-8573.

  • Received October 13, 1997.
  • Accepted May 1, 1998.
  • ©1998 American Association for Cancer Research.
PreviousNext
Back to top
July 1998
Volume 58, Issue 13
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effective Adoptive Immunotherapy by T-LAK Cells Retargeted with Bacterial Superantigen-conjugated Antibody to MUC1 in Xenografted Severe Combined Immunodeficient Mice
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effective Adoptive Immunotherapy by T-LAK Cells Retargeted with Bacterial Superantigen-conjugated Antibody to MUC1 in Xenografted Severe Combined Immunodeficient Mice
Masao Shinoda, Toshio Kudo, Masanori Suzuki, Yu Katayose, Naoki Sakurai, Hisaaki Saeki, Hideaki Kodama, Kenji Fukuhara, Kohzoh Imai, Yuji Hinoda and Seiki Matsuno
Cancer Res July 1 1998 (58) (13) 2838-2843;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effective Adoptive Immunotherapy by T-LAK Cells Retargeted with Bacterial Superantigen-conjugated Antibody to MUC1 in Xenografted Severe Combined Immunodeficient Mice
Masao Shinoda, Toshio Kudo, Masanori Suzuki, Yu Katayose, Naoki Sakurai, Hisaaki Saeki, Hideaki Kodama, Kenji Fukuhara, Kohzoh Imai, Yuji Hinoda and Seiki Matsuno
Cancer Res July 1 1998 (58) (13) 2838-2843;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

Regular Articles

  • Chemically Induced Mutations in Mitochondrial DNA of Human Cells: Mutational Spectrum of N-Methyl-N′-nitro-N-nitrosoguanidine
  • Squalamine Inhibits Angiogenesis and Solid Tumor Growth in Vivo and Perturbs Embryonic Vasculature
  • Human Chromosome 21 Determines Growth Factor Dependence in Human/Mouse B-Cell Hybridomas
Show more Regular Articles

Immunology

  • Abstract 6644: A comprehensive in vitro and in vivo system to evaluate STING agonist efficacy in cancer therapeutics
  • Abstract 6686: SO-C101 displays strong anti-tumor effect in TC-1 and TRAMP-C2 tumor mice and in combination with PD-1 blockade prevents tumor development in a NK and CD8+ T cells dependent manner
  • Abstract 6707: Inhibition of proteolytic cleavage of NKG2D ligands increases immune cell-mediated cell killing of tumor cells in vitro
Show more Immunology

Articles

  • Abstract 6644: A comprehensive in vitro and in vivo system to evaluate STING agonist efficacy in cancer therapeutics
  • Abstract 6686: SO-C101 displays strong anti-tumor effect in TC-1 and TRAMP-C2 tumor mice and in combination with PD-1 blockade prevents tumor development in a NK and CD8+ T cells dependent manner
  • Abstract 6707: Inhibition of proteolytic cleavage of NKG2D ligands increases immune cell-mediated cell killing of tumor cells in vitro
Show more Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement